New Clot-Busting device could offer quick relief for lung blood clots

NCT ID NCT05821426

Not yet recruiting Disease control Sponsor: Magneto Thrombectomy Solutions Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new device called the eTrieve PE Kit to remove blood clots from the lungs in people with a moderate-risk pulmonary embolism. About 130 adults will be enrolled to see if the device is safe and effective at improving blood flow and reducing complications. The goal is to offer a faster, less invasive treatment option for this serious condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: eTrieve PE Kit (a device to remove blood clots from the lungs)
What this could lead to: If successful, this could provide a new, less invasive way to quickly remove dangerous blood clots from the lungs, potentially reducing complications and hospital stays.
What could go wrong: This is an early-stage study with only 130 participants and no comparison group, so results may not apply to everyone. The procedure carries risks like any invasive device, including bleeding or damage to blood vessels.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pulmonary embolism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PULMONARY EMBOLISM

More trials for these conditions

Other studies related to the condition(s) this trial covers.